Glomerulonephritis: Management in general practice

Australian Family Physician

Volumn 34, Issue 11, 2005, Pages 907-913

  Isbel, Nicole M ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; CHILD; FOCAL GLOMERULOSCLEROSIS; GENERAL PRACTICE; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGY; MEMBRANOUS GLOMERULONEPHRITIS; METABOLISM; METHODOLOGY; NEPHROTIC SYNDROME; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; REVIEW; STREPTOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHILD; FAMILY PRACTICE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEPHROTIC SYNDROME; PHYSICIAN'S ROLE; PRACTICE GUIDELINES; STREPTOCOCCAL INFECTIONS; VASCULITIS;

EID: 33644833560     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (12)

1. McDonald S, Russ G. ANZATA Registry Report 2003. Adelaide: South Australia, 2003.
2. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003;14:S131-8.
3. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996;49:800-5.
4. Harris RC, Ismail N. Extrarenal complications of the nephrotic syndrome. Am J Kidney Dis 1994;23:477-97.5. The CARI Guidelines (Caring for Australians with Renal Impairment). Australian Kidney Foundation & Australia New Zealand Society of Nephrology, 2001
5. The CARI Guidelines (Caring for Australians with Renal Impairment). Australian Kidney Foundation & Australia New Zealand Society of Nephrology, 2001.
6. Floege J, Feehally J. IgA nephropathy: recent developments. J Am Soc Nephrol 2000;11:2395-403.
7. Campbell R, Sangalli F, Perticucci E, et al. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int 2003;63:1094-103.
8. Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E. Treatment of IgA nephropathy with ACE inhibitors: a randomised and controlled trial. J Am Soc Nephrol 2003;14:1578-83.
9. Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomised, controlled trial. J Am Soc Nephrol 2004;15:157-63.
10. Dillon JJ. Fish oil therapy for IgA nephropathy: efficacy and interstudy variability. J Am Soc Nephrol 1997;8:1739-44.
11. Cameron JS. Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant 2003;18(Suppl 6):vi45-vi51.12. National Health and Medical Research Council. The Australian immunisation handbook. 8th ed. Canberra: NHMRC, 2003.
12. National Health and Medical Research Council. The Australian immunisation handbook. 8th ed. Canberra: NHMRC, 2003.